Drug Screening Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
The global drug screening market reached a value of US$ 5.42 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 9.36 Billion by 2027, exhibiting a CAGR of 9.30% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Drug screening includes analysis of blood, urine, hair, or saliva specimens using immunoassays (IAs) or gas chromatography (GC) with mass spectrometry (MS) to detect the presence of a drug in the body. It is utilized in various settings for different purposes, including clinical care, occupational health, legal prosecution, rehabilitation, and risk management. For instance, it is used in different medical settings to assist the triage of patients with altered mental status in rehabilitation. It also finds application in assessing abuse potential and adherence among patients that are receiving opioid therapy. Nowadays, several manufacturers are introducing devices that can auto verify results as per the patient's electronic medical record in lesser time.
Drug Screening Market Trends:
Drug abuse can cause adverse safety and health impacts and lower the productivity and morale of employees. This, along with growing emphasis on creating a safe workplace, is positively influencing the use of drug screening in private companies to prevent employee substance abuse. In addition, governing agencies of various countries are mandating random drug screening for personnel law enforcement, military, national security, and public health. Furthermore, the rising number of fatal road accidents is catalyzing the demand for drug screening to maintain road safety worldwide. Apart from this, drug screening is used in sports and athletic competitions to detect performance-enhancing drugs, such as steroids and human growth hormone (HGH), in professional athletes. This, in confluence with the increasing participation of individuals in professional sports, is contributing to market growth. Moreover, substantial growth in pain management and opioid dependency clinics is anticipated to drive the demand for drug screening across the globe.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global drug screening market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product and service, sample type and end user.
Breakup by Product and Service:
Equipment
Immunoassay Analyzers
Chromatography Instruments
Breath Analyzers
Rapid Testing Devices
Urine Testing Devices
Oral Fluid Testing Devices
Consumables
Assay Kits
Sample Collection Cups
Calibrators and Controls
Others
Laboratory Services
Breakup by Sample Type:
Urine Samples
Breath Samples
Oral Fluid Samples
Hair Samples
Others
Breakup by End User:
Hospitals
Drug Testing Laboratories
Workplaces
Drug Treatment Centers
Pain Management Centers
Personal Users
Criminal Justice System and Law Enforcement Agencies
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Alfa Scientific Designs Inc., Bio-Rad Laboratories Inc., Drдgerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings, Lifeloc Technologies Inc., Omega Laboratories Inc., OraSure Technologies Inc., Psychemedics Corporation, Quest Diagnostics Incorporated, Siemens AG and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report:
How has the global drug screening market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global drug screening market?
What are the key regional markets?
What is the breakup of the market based on the product and service?
What is the breakup of the market based on the sample type?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global drug screening market and who are the key players?
What is the degree of competition in the industry?
Drug screening includes analysis of blood, urine, hair, or saliva specimens using immunoassays (IAs) or gas chromatography (GC) with mass spectrometry (MS) to detect the presence of a drug in the body. It is utilized in various settings for different purposes, including clinical care, occupational health, legal prosecution, rehabilitation, and risk management. For instance, it is used in different medical settings to assist the triage of patients with altered mental status in rehabilitation. It also finds application in assessing abuse potential and adherence among patients that are receiving opioid therapy. Nowadays, several manufacturers are introducing devices that can auto verify results as per the patient's electronic medical record in lesser time.
Drug Screening Market Trends:
Drug abuse can cause adverse safety and health impacts and lower the productivity and morale of employees. This, along with growing emphasis on creating a safe workplace, is positively influencing the use of drug screening in private companies to prevent employee substance abuse. In addition, governing agencies of various countries are mandating random drug screening for personnel law enforcement, military, national security, and public health. Furthermore, the rising number of fatal road accidents is catalyzing the demand for drug screening to maintain road safety worldwide. Apart from this, drug screening is used in sports and athletic competitions to detect performance-enhancing drugs, such as steroids and human growth hormone (HGH), in professional athletes. This, in confluence with the increasing participation of individuals in professional sports, is contributing to market growth. Moreover, substantial growth in pain management and opioid dependency clinics is anticipated to drive the demand for drug screening across the globe.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global drug screening market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product and service, sample type and end user.
Breakup by Product and Service:
Equipment
Immunoassay Analyzers
Chromatography Instruments
Breath Analyzers
Rapid Testing Devices
Urine Testing Devices
Oral Fluid Testing Devices
Consumables
Assay Kits
Sample Collection Cups
Calibrators and Controls
Others
Laboratory Services
Breakup by Sample Type:
Urine Samples
Breath Samples
Oral Fluid Samples
Hair Samples
Others
Breakup by End User:
Hospitals
Drug Testing Laboratories
Workplaces
Drug Treatment Centers
Pain Management Centers
Personal Users
Criminal Justice System and Law Enforcement Agencies
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Alfa Scientific Designs Inc., Bio-Rad Laboratories Inc., Drдgerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings, Lifeloc Technologies Inc., Omega Laboratories Inc., OraSure Technologies Inc., Psychemedics Corporation, Quest Diagnostics Incorporated, Siemens AG and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report:
How has the global drug screening market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global drug screening market?
What are the key regional markets?
What is the breakup of the market based on the product and service?
What is the breakup of the market based on the sample type?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global drug screening market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL DRUG SCREENING MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT AND SERVICE
6.1 Equipment
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Immunoassay Analyzers
6.1.2.2 Chromatography Instruments
6.1.2.3 Breath Analyzers
6.1.3 Market Forecast
6.2 Rapid Testing Devices
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Urine Testing Devices
6.2.2.2 Oral Fluid Testing Devices
6.2.3 Market Forecast
6.3 Consumables
6.3.1 Market Trends
6.3.2 Key Segments
6.3.2.1 Assay Kits
6.3.2.2 Sample Collection Cups
6.3.2.3 Calibrators and Controls
6.3.2.4 Others
6.3.3 Market Forecast
6.4 Laboratory Services
6.4.1 Market Trends
6.4.2 Market Forecast
7 MARKET BREAKUP BY SAMPLE TYPE
7.1 Urine Samples
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Breath Samples
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Oral Fluid Samples
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Hair Samples
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 MARKET BREAKUP BY END USER
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Drug Testing Laboratories
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Workplaces
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Drug Treatment Centers
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Pain Management Centers
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Personal Users
8.6.1 Market Trends
8.6.2 Market Forecast
8.7 Criminal Justice System and Law Enforcement Agencies
8.7.1 Market Trends
8.7.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Alfa Scientific Designs Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Bio-Rad Laboratories Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Drдgerwerk AG & Co. KGaA
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Laboratory Corporation of America Holdings
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6 Lifeloc Technologies Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 Omega Laboratories Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 OraSure Technologies Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Psychemedics Corporation
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 Quest Diagnostics Incorporated
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.11 Siemens AG
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Thermo Fisher Scientific Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL DRUG SCREENING MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT AND SERVICE
6.1 Equipment
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Immunoassay Analyzers
6.1.2.2 Chromatography Instruments
6.1.2.3 Breath Analyzers
6.1.3 Market Forecast
6.2 Rapid Testing Devices
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Urine Testing Devices
6.2.2.2 Oral Fluid Testing Devices
6.2.3 Market Forecast
6.3 Consumables
6.3.1 Market Trends
6.3.2 Key Segments
6.3.2.1 Assay Kits
6.3.2.2 Sample Collection Cups
6.3.2.3 Calibrators and Controls
6.3.2.4 Others
6.3.3 Market Forecast
6.4 Laboratory Services
6.4.1 Market Trends
6.4.2 Market Forecast
7 MARKET BREAKUP BY SAMPLE TYPE
7.1 Urine Samples
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Breath Samples
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Oral Fluid Samples
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Hair Samples
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 MARKET BREAKUP BY END USER
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Drug Testing Laboratories
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Workplaces
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Drug Treatment Centers
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Pain Management Centers
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Personal Users
8.6.1 Market Trends
8.6.2 Market Forecast
8.7 Criminal Justice System and Law Enforcement Agencies
8.7.1 Market Trends
8.7.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Alfa Scientific Designs Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Bio-Rad Laboratories Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Drдgerwerk AG & Co. KGaA
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Laboratory Corporation of America Holdings
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6 Lifeloc Technologies Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 Omega Laboratories Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 OraSure Technologies Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Psychemedics Corporation
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 Quest Diagnostics Incorporated
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.11 Siemens AG
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Thermo Fisher Scientific Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Drug Screening Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Drug Screening Market Forecast: Breakup by Product and Service (in Million US$), 2022-2027
Table 3: Global: Drug Screening Market Forecast: Breakup by Sample Type (in Million US$), 2022-2027
Table 4: Global: Drug Screening Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Drug Screening Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Drug Screening Market: Competitive Structure
Table 7: Global: Drug Screening Market: Key Players
Table 1: Global: Drug Screening Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Drug Screening Market Forecast: Breakup by Product and Service (in Million US$), 2022-2027
Table 3: Global: Drug Screening Market Forecast: Breakup by Sample Type (in Million US$), 2022-2027
Table 4: Global: Drug Screening Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Drug Screening Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Drug Screening Market: Competitive Structure
Table 7: Global: Drug Screening Market: Key Players
LIST OF FIGURES
Figure 1: Global: Drug Screening Market: Major Drivers and Challenges
Figure 2: Global: Drug Screening Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Drug Screening Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Drug Screening Market: Breakup by Product and Service (in %), 2021
Figure 5: Global: Drug Screening Market: Breakup by Sample Type (in %), 2021
Figure 6: Global: Drug Screening Market: Breakup by End User (in %), 2021
Figure 7: Global: Drug Screening Market: Breakup by Region (in %), 2021
Figure 8: Global: Drug Screening (Equipment) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Drug Screening (Equipment) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Drug Screening (Rapid Testing Devices) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Drug Screening (Rapid Testing Devices) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Drug Screening (Consumables) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Drug Screening (Consumables) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Drug Screening (Laboratory Services) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Drug Screening (Laboratory Services) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Drug Screening (Urine Samples) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Drug Screening (Urine Samples) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Drug Screening (Breath Samples) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Drug Screening (Breath Samples) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Drug Screening (Oral Fluid Samples) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Drug Screening (Oral Fluid Samples) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Drug Screening (Hair Samples) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Drug Screening (Hair Samples) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Drug Screening (Other Sample Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Drug Screening (Other Sample Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Drug Screening (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Drug Screening (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Drug Screening (Drug Testing Laboratories) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Drug Screening (Drug Testing Laboratories) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Drug Screening (Workplaces) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Drug Screening (Workplaces) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Drug Screening (Drug Treatment Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Drug Screening (Drug Treatment Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Drug Screening (Pain Management Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Drug Screening (Pain Management Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Global: Drug Screening (Personal Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Global: Drug Screening (Personal Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Global: Drug Screening (Criminal Justice System and Law Enforcement Agencies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Global: Drug Screening (Criminal Justice System and Law Enforcement Agencies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: North America: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: North America: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: United States: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: United States: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Canada: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Canada: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Asia-Pacific: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Asia-Pacific: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: China: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: China: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Japan: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Japan: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: India: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: India: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: South Korea: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: South Korea: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Australia: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Australia: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Indonesia: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Indonesia: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Others: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Others: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Europe: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Europe: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Germany: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Germany: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: France: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: France: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: United Kingdom: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: United Kingdom: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Italy: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Italy: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Spain: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Spain: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Russia: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Russia: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Others: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Others: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Latin America: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Latin America: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Brazil: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Brazil: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Mexico: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Mexico: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Others: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 85: Others: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 86: Middle East and Africa: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 87: Middle East and Africa: Drug Screening Market: Breakup by Country (in %), 2021
Figure 88: Middle East and Africa: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Global: Drug Screening Industry: SWOT Analysis
Figure 90: Global: Drug Screening Industry: Value Chain Analysis
Figure 91: Global: Drug Screening Industry: Porter's Five Forces Analysis
Figure 1: Global: Drug Screening Market: Major Drivers and Challenges
Figure 2: Global: Drug Screening Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Drug Screening Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Drug Screening Market: Breakup by Product and Service (in %), 2021
Figure 5: Global: Drug Screening Market: Breakup by Sample Type (in %), 2021
Figure 6: Global: Drug Screening Market: Breakup by End User (in %), 2021
Figure 7: Global: Drug Screening Market: Breakup by Region (in %), 2021
Figure 8: Global: Drug Screening (Equipment) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Drug Screening (Equipment) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Drug Screening (Rapid Testing Devices) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Drug Screening (Rapid Testing Devices) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Drug Screening (Consumables) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Drug Screening (Consumables) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Drug Screening (Laboratory Services) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Drug Screening (Laboratory Services) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Drug Screening (Urine Samples) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Drug Screening (Urine Samples) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Drug Screening (Breath Samples) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Drug Screening (Breath Samples) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Drug Screening (Oral Fluid Samples) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Drug Screening (Oral Fluid Samples) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Drug Screening (Hair Samples) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Drug Screening (Hair Samples) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Drug Screening (Other Sample Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Drug Screening (Other Sample Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Drug Screening (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Drug Screening (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Drug Screening (Drug Testing Laboratories) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Drug Screening (Drug Testing Laboratories) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Drug Screening (Workplaces) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Drug Screening (Workplaces) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Drug Screening (Drug Treatment Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Drug Screening (Drug Treatment Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Drug Screening (Pain Management Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Drug Screening (Pain Management Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Global: Drug Screening (Personal Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Global: Drug Screening (Personal Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Global: Drug Screening (Criminal Justice System and Law Enforcement Agencies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Global: Drug Screening (Criminal Justice System and Law Enforcement Agencies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: North America: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: North America: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: United States: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: United States: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Canada: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Canada: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Asia-Pacific: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Asia-Pacific: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: China: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: China: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Japan: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Japan: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: India: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: India: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: South Korea: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: South Korea: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Australia: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Australia: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Indonesia: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Indonesia: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Others: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Others: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Europe: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Europe: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Germany: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Germany: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: France: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: France: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: United Kingdom: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: United Kingdom: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Italy: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Italy: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Spain: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Spain: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Russia: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Russia: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Others: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Others: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Latin America: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Latin America: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Brazil: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Brazil: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Mexico: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Mexico: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Others: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 85: Others: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 86: Middle East and Africa: Drug Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 87: Middle East and Africa: Drug Screening Market: Breakup by Country (in %), 2021
Figure 88: Middle East and Africa: Drug Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Global: Drug Screening Industry: SWOT Analysis
Figure 90: Global: Drug Screening Industry: Value Chain Analysis
Figure 91: Global: Drug Screening Industry: Porter's Five Forces Analysis
